Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
05/2007
05/24/2007WO2007024756A3 Reduced genome e. coli
05/24/2007WO2007022030A3 Methods and compositions for the efficient delivery of therapeutic agents to cells and animals
05/24/2007WO2007017907A3 A novel nucleic acid encoding a novel protein of candida albicans and uses thereof
05/24/2007WO2007015935A9 Diagnostic methods for the prediction of therapeutic success, recurrence free and overall survival in cancer therapy
05/24/2007WO2007014275A3 Targeted integration and expression of exogenous nucleic acid sequences
05/24/2007WO2007013979A3 Methods for increasing efficiency of homologous recombination
05/24/2007WO2007011736A3 Yield increase in plants overexpressing the shsrp genes
05/24/2007WO2006135431A3 Inhibition of metallo-beta-lactamase by rna
05/24/2007WO2006133210A3 Mannitol induced promoter systems in bacterial host cells
05/24/2007WO2006133099A3 Sirna microbicides for preventing and treating viral diseases
05/24/2007WO2006130855A9 Method of targeted gene delivery using viral vectors
05/24/2007WO2006119150A3 Compositions and methods for targeting of viral vectors
05/24/2007WO2006102652A3 Expression of soluble, active eukaryotic glycosyltransferases in prokaryotic organisms
05/24/2007WO2006100681A3 Human synthetic single-chain antibodies directed against the common epitope of mutant p53 and their uses
05/24/2007WO2006098998A3 Methods and compositions for modulating vascular integrity
05/24/2007WO2006039582A3 Compositions and methods for diagnosing and treating brain cancer and identifying neural stem cells
05/24/2007WO2005123959A3 Multiplexing assays for analyte detection
05/24/2007WO2005112622A3 Regulation of transcription with a cis-acting ribozyme
05/24/2007WO2005097205A8 Dna virus microrna and methods for inhibiting same
05/24/2007WO2005049640A3 Rhesus monkey dickkopf-1, nucleotides encoding same, and uses thereof
05/24/2007WO2003084471A3 Compositions selective for adenosine diphosphate and methods of using same
05/24/2007US20070118934 Chimeric toxin receptor proteins and chimeric toxin receptor proteins for treatment and prevention of anthrax
05/24/2007US20070118933 Seed-specific gene promoters and uses thereof
05/24/2007US20070118932 Plants having improved yield and method for making the same
05/24/2007US20070118931 Plants having modified growth characteristics and method for making the same
05/24/2007US20070118930 Polypeptides having cellobiase activity and polynucleotides encoding same
05/24/2007US20070118929 Delta-9 elongases and their use in making polyunsaturated fatty acids
05/24/2007US20070118928 Transgenic plant and method for altering oil and protein plant content
05/24/2007US20070118927 Modification of fatty acid biosynthesis using recombinant diacylglycerol acyltransferase sequences from ryegrass (lolium) and fescue (festuca)
05/24/2007US20070118926 Engineering broad spectrum virus disease resistance in plants based on the regulation of expression of the RNA dependant RNA polymerase 6 gene
05/24/2007US20070118925 Plastid Transit Peptides
05/24/2007US20070118924 Novel bacillus thuringiensis isolate active against lepidopteran pests, and genes encoding novel lepidopteran-active toxins
05/24/2007US20070118923 regulating gene expression in plants
05/24/2007US20070118922 Novel plant promoter
05/24/2007US20070118920 Herbicide-resistant sunflower plants, polynucleotides encoding herbicide-resistant acetohydroxyacid synthase large subunit proteins, and methods of use
05/24/2007US20070118919 Inbred Corn Line PHCER
05/24/2007US20070118918 comprising a promoter with maize endosperm-specific expression operably linked to heterologous DNA; transgenic maize plant cell; improved stress tolerance, yield, process and storage quality
05/24/2007US20070118917 Recombinant DNA constructs and methods for controlling gene expression
05/24/2007US20070118916 Process for the production of fine chemicals
05/24/2007US20070117970 generating an immune response, comprising administering to a mammal variable major protein (VMP)-like polypeptides as antigens for immunoprophylaxis, immunotherapy and immunodiagnosis; antibodies; Lyme disease
05/24/2007US20070117969 PTH receptor and screening assay utilizing the same
05/24/2007US20070117968 Metal binding proteins and associated methods
05/24/2007US20070117773 Telomerase-inhibiting ENA oligonucleotide
05/24/2007US20070117772 Methods for slowing familial ALS disease progression
05/24/2007US20070117771 VGLUT-specific dsRNA compounds
05/24/2007US20070117769 Methods of modulating cell cycle and cell signaling pathways using biliverdin reductase
05/24/2007US20070117768 Arteriosclerosis, promoting the healing of wounds, treating AIDS, cancer, Alzheimer's disease, systemic lupus erythematosus as well a rheumatoid arthritis and other chronic inflammatory diseases
05/24/2007US20070117767 siRNA Molecules and Method of Suppressing Gene Expression With the Use of the Same
05/24/2007US20070117766 Vigilant cells
05/24/2007US20070117756 FVII or FVIIa Gla domain variants
05/24/2007US20070117754 Nectin polypeptides, polynucleotides, methods of making and use thereof
05/24/2007US20070117749 Production of mersacidin and its variants in SigH and/or mrsA negative bacillus host cells
05/24/2007US20070117748 Novel apoptosis-modulating proteins, dna encoding the proteins and methods of use thereof
05/24/2007US20070117742 producing a fraction enriched in a proteinaceous molecule having N-linked glycans comprising sialyl-Lewis X, Lewis X or LacdiNac structures; cerebral ischemia or myocardial infarction; composition comprising erythropoietin molecules
05/24/2007US20070117202 Novel nucleic acid molecule
05/24/2007US20070117198 Industrial producing strain of the fungus Claviceps purpurea (Fr.) Tul.
05/24/2007US20070117197 Lactobacilli expressing biologically active polypeptides and uses thereof
05/24/2007US20070117196 Transformed microorganism comprising an isolated fragment of DNA derived from coffee and integrated into the genome or plasmid of the mannase; involved in the hydrolysis of polysaccharides
05/24/2007US20070117192 Production of 3-hydroxycarboxylic acid using nitrilase mutants
05/24/2007US20070117191 Reductase gene for alpha-substituted-alpha, beta-unsaturated carbonyl compound
05/24/2007US20070117190 Delta-9 elongases and their use in making polyunsaturated fatty acids
05/24/2007US20070117189 Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes
05/24/2007US20070117187 Tools and methods useful in characterising the immunotoxic activity of xenobiotic substances
05/24/2007US20070117186 Highly efficient secretory signal peptide and a protein expression system using the peptide thereof
05/24/2007US20070117184 In vivo incorporation of unnatural amino acids
05/24/2007US20070117183 Corynebacterium glutamicum genes encoding metabolic pathway proteins
05/24/2007US20070117180 Enzyme producing plasma protein fragment having inhibitory activity to metastasis and growth of cancer and plasma protein fragment produced by fragmentation by said enzyme
05/24/2007US20070117169 Using fluorescence-labeled glucan binding domain protein in the diagnosis of mycosis; detecting a trace amount of a fungal component
05/24/2007US20070117166 Use of ULIP proteins in the diagnosis and therapy of cancers and paraneoplastic neurological syndromes
05/24/2007US20070117165 Detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells
05/24/2007US20070117162 Kidney-specific urate transporter and gene thereof
05/24/2007US20070117161 Antibody Specific for Human 4-1BB Receptor
05/24/2007US20070117160 Novel method of screening
05/24/2007US20070117159 Isolated polypeptide comprising a claimed amino acid sequence
05/24/2007US20070117155 Drug screening for agonists and antagonists of the mammalian histamine receptor; for inflammation, asthma, and allergy, atopic dermatitis, stroke, myocardial infection, migraine, COPD, rheumatoid arthritis, multiple sclerosis, inflammatory bowel disease, and psoriasis
05/24/2007US20070117146 Allelic variants of GPR50
05/24/2007US20070117145 Interferon-alpha induced genes
05/24/2007US20070117142 Regulation of novel human asparagine-hydroxylases
05/24/2007US20070117141 Identification and cloning of a full-length human clnk-related gene, MIST (mast cell immunoreceptor signal transducer)
05/24/2007US20070117140 Method for selecting antimicrobial agent and utilization thereof
05/24/2007US20070117139 Method of manufacturing probe carrier
05/24/2007US20070117138 Splice variant cannabinoid receptor (cb1b)
05/24/2007US20070117137 Amplification of target nucleic acid; obtain nucleotide sequences, incubate with primers, expose to reaction miture and polymerase, amplify, recover reaction product
05/24/2007US20070117136 Detection of microsatellite instability and its use in diagnosis of tumors
05/24/2007US20070117126 Shotgun scanning
05/24/2007US20070117119 Carriers having biological substance
05/24/2007US20070117113 Use of DNA to produce compounds exhibiting antibiotic activity based on the anthramycin structures
05/24/2007US20070117112 Materials and methods for the generation of fully 2'-modified nucleic acid transcripts
05/24/2007US20070117107 rRNA genes from E. coli and other disease causing organisms are genetically engineered to allow identification of functional mutant ribosomes that may be used as drug targets
05/24/2007US20070117098 'signalin' family of TGFbeta signal transduction proteins and uses related thereto
05/24/2007US20070117097 Novel proteins and novel genes encoding the same
05/24/2007US20070117090 Processing nucleic acid
05/24/2007US20070116765 Aqueous dispersion of hydrogel nanoparticles with inverse thermoreversible gelation
05/24/2007US20070116744 Polysaccharide lyases for use in laundering detergents, textile treatment and food processing
05/24/2007US20070116726 Immunisation against Chlamydia pneumoniae
05/24/2007US20070116725 Live Attenuated Samonella Strains for Producing Monovalent or Multivalent Vaccines
05/24/2007US20070116721 Hepatitis B virus pre-S1 derived synthetic polypeptides and uses thereof
05/24/2007US20070116718 Fusion proteins comprising bacteriophage coat protein and asingle-chain T cell receptor
05/24/2007US20070116715 Genetically modified cholera toxin (CT-CRM) comprising reduced toxicity and enhanced immunological response for use in preparation of vaccines against parasitic infection
05/24/2007US20070116712 Novel streptococcus antigens